Veterinary Vaccines Market to Grow with a CAGR of 7.28% through 2030F

Increase in the awareness of animal welfare and increase in the pet ownership is expected to drive the Global Veterinary Vaccines Market growth in the forecast period, 2026-2030F

According to TechSci Research report, “Veterinary Vaccines Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Veterinary Vaccines Market stood at USD 8.44 billion in 2024 and is anticipated to grow with a CAGR of 7.28% in the forecast period. 

The global veterinary vaccine market is significantly influenced by the increasing incidence of infectious diseases among animals. These diseases can affect various species, including livestock (cattle, poultry, swine) and companion animals (dogs, cats). Examples of such diseases include foot-and-mouth disease, avian influenza, bovine respiratory disease, and canine parvovirus. For instance, between January and June 2024, 55 countries reported over 3,800 wildlife disease outbreaks, affecting 151 species, with 10% at risk of extinction. Highly pathogenic avian influenza (HPAI) and African swine fever (ASF) accounted for most cases, significantly impacting wildlife and domestic animals. Protecting wildlife health is crucial for safeguarding food security, biodiversity, and human well-being. Animal diseases can have severe economic consequences. Outbreaks can lead to reduced livestock productivity, increased mortality rates, and trade restrictions. For farmers and livestock producers, this translates into substantial financial losses. To mitigate these impacts, vaccines are developed and administered to prevent the occurrence and spread of these diseases. The concept of One Health emphasizes the interconnectedness of human, animal, and environmental health. Preventing animal diseases is not only essential for the well-being of animals but also for public health. Diseases that can jump from animals to humans (zoonoses) highlight the importance of veterinary vaccines in safeguarding both animal and human populations.

The emergence of new and unpredictable animal diseases can pose significant challenges to the veterinary vaccine market. Developing vaccines for these diseases often requires extensive research and development, and the timeline to market may not align with the urgency of addressing disease outbreaks. Some pathogens, like influenza viruses, exhibit antigenic variability, meaning they can mutate over time. This variability can render existing vaccines less effective, necessitating frequent updates and reformulations. This poses technical and logistical challenges for vaccine manufacturers to stay ahead of evolving pathogens. Some diseases, particularly zoonotic diseases that can be transmitted between animals and humans, may have reservoir hosts in wildlife. Controlling these diseases through vaccination can be challenging due to the difficulty of vaccinating wild animals.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Veterinary Vaccines Market”

The Global Veterinary Vaccines Market is segmented into vaccine type, technology, regional distribution, and company.

Based on vaccine type, ​the companion animal vaccine segment is currently the fastest-growing in the global veterinary vaccines market. This surge is primarily driven by increased pet ownership and heightened awareness of animal health. Pet owners are increasingly prioritizing preventive healthcare, leading to a higher demand for vaccinations. For instance, Zoetis reported an 18% increase in revenue from its companion animal segment in the first quarter of 2024, attributed to strong demand for pet medicines and vaccines. COVID-19 pandemic saw a significant rise in pet adoptions, further fueling the need for companion animal vaccines. Advancements in vaccine technology and the introduction of new products have enhanced the efficacy and safety of these vaccines, encouraging their adoption. Consequently, the companion animal vaccine segment is experiencing robust growth, outpacing the livestock vaccine segment.​

Based on region, the Asia-Pacific market is poised to be the fastest-growing market, offering lucrative growth opportunities for Veterinary Vaccines players during the forecast period. Factors As APAC countries undergo rapid urbanization and economic development, there is an increasing demand for animal protein, leading to a growing livestock industry. Countries like China and India have rapidly expanding pet populations, with pet owners showing greater awareness of and willingness to invest in pet healthcare, including vaccinations. Some APAC countries face ongoing challenges with endemic diseases in livestock and poultry. Governments and farmers are increasingly turning to vaccines as a means of disease control to ensure food security. The region is witnessing increased investment in veterinary healthcare infrastructure, including vaccination programs and research and development of new vaccines. Some APAC governments are implementing policies to boost the production of animal-derived products, which includes promoting vaccination to improve livestock health.

Major companies operating in Global Veterinary Vaccines Market are:

• Zoetis Inc.
• Merck & Co. Inc.
• Virbac SA
• Hester Biosciences Limited
• Elanco Animal Health
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Phibro Animal Health Corporation
• HIPRA

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global veterinary vaccine market is experiencing significant expansion, driven by globalization and increased trade in animal products. Several related trends contribute to this growth: Emerging markets in Asia, Latin America, and Africa are witnessing a rise in demand for veterinary vaccines. As these regions undergo economic development and urbanization, the demand for animal protein and pet ownership is increasing, driving the need for vaccines. The international trade of animals and animal products necessitates compliance with international health and safety standards. This, in turn, boosts the demand for vaccines to ensure the health and safety of animals in transit. Vaccine manufacturers are forming collaborations and partnerships to expand their global presence and access new markets. This includes joint ventures, licensing agreements, and distribution partnerships”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Veterinary Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Livestock Vaccine, Companion Animal Vaccine), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other), By Region & Competition 2020-2030F”, has evaluated the future growth potential of Global Veterinary Vaccines Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Veterinary Vaccines Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com